Search results
Found 1069 matches for
An internationally recognised centre of excellence for biomedical and clinical research and teaching
National survey reveals big reductions in COVID-19 infections with single dose of Oxford-AZ and Pfizer vaccines
Coronavirus COVID-19 Research
23 April 2021
Data from the COVID-19 Infection Survey, a partnership between the University of Oxford, the Office of National Statistics (ONS) and the Department for Health and Social Care (DHSC), is the first to show the impact of vaccination on antibody responses and new infections in a large group of adults from the general population aged 16 years and older.
Research uncovers high risk to pregnant women from COVID-19
Coronavirus COVID-19 Research
23 April 2021
A study of more than 2,100 pregnant women across 18 countries worldwide has revealed that COVID-19 is associated with a higher risk of severe maternal and newborn complications than previously recognised.
General anaesthesia should be available for dying patients - medical and ethical experts
General Research
21 April 2021
General anaesthesia should be more widely available for patients at the end of their lives, according to Oxford experts in ethics and anaesthesia, according to a paper published by Anaesthesia (a journal of the Association of Anaesthetists).
Risk of rare blood clotting higher for COVID-19 than for vaccines
Coronavirus COVID-19 Research
15 April 2021
COVID-19 leads to a several-times higher risk of cerebral venous thrombosis (CVT) blood clots than current COVID-19 vaccines.
Asthma drug budesonide shortens recovery time in non-hospitalised patients with COVID-19
Clinical Trials Coronavirus COVID-19 Research
12 April 2021
Inhaled budesonide, a common corticosteroid, is the first widely available, inexpensive drug found to shorten recovery times in COVID-19 patients aged over 50 who are treated at home and in other community settings, reports the PRINCIPLE trial in 1,779 participants.
Link between COVID-19 infection and subsequent mental health and neurological conditions found
Coronavirus COVID-19 General Research
7 April 2021
One in three COVID-19 survivors received a neurological or psychiatric diagnosis within six months of infection with the SARS-CoV-2 virus, an observational study of more than 230,000 patient health records published in The Lancet Psychiatry journal estimates. The study looked at 14 neurological and mental health disorders.
Cognitive behavioural therapy: we discovered a data gap on its effectiveness for different ethnic groups
General Research
7 April 2021
New national study of long-term impacts of debilitating lung damage from COVID-19
Coronavirus COVID-19 General Research
7 April 2021
A new national study will investigate the long-term effects of lung inflammation and scarring from COVID-19. The study, launched with £2 million of funding from UK Research and Innovation (UKRI), aims to develop treatment strategies and prevent disability.
Opportunities for final goodbyes must be prioritised in COVID-19 pandemic
Coronavirus COVID-19 General Research
31 March 2021
Bereaved relatives described the ongoing pain of being absent at the end of a loved-one's life. Many had not seen their relative for weeks or months due to the pandemic. Opportunities must be prioritised for essential connections between families at end-of-life care.
New study shows overwhelming public support for donating vaccines to low-income countries
Coronavirus COVID-19 General Research
31 March 2021
A survey led by Nuffield Department of Population Health's Health Economics Research Centre has found that most people in high-income countries support donating some of their country’s COVID-19 vaccine supplies to low-income nations who would otherwise struggle to gain access.
New target identified to develop treatment for Abdominal Aortic Aneurysm
General Research
30 March 2021
A new study from the Department of Physiology, Anatomy & Genetics (DPAG) has shed light on a key regulatory step in the initiation and progression of Abdominal Aortic Aneurysm by revealing the protective role of a previously little known small protein.
Food and drink products with pro-environment ‘ecolabels’ are more appealing to shoppers – new research
General Research
29 March 2021
MRC HIU researchers release cheap, quick COVID-19 antibody test
Coronavirus COVID-19 General Research
29 March 2021
An international research team led by Oxford University scientists has developed a portable test for antibodies that fight the novel coronavirus that causes COVID-19.
New study finds strong immune response following COVID-19 vaccination
Coronavirus COVID-19 General Research
29 March 2021
A new study has found that 99% of people generate a robust immune response against COVID-19 after just one dose of the Pfizer vaccine, and that after two doses levels of protection were even stronger.
AstraZeneca publish primary analysis from US trial of coronavirus vaccine
Clinical Trials Coronavirus COVID-19 General Research
25 March 2021
Our partners AstraZeneca have today announced the high-level results from the primary analysis of their Phase III trial of the ChAdOx1 nCoV-19 coronavirus vaccine in the US. They confirm that the vaccine efficacy is consistent with the interim analysis results announced on Monday 22 March 2021.
New partnership enables access to state-of-the-art radiotherapy machine
General Research
25 March 2021
The first NHS patient has received treatment on the cutting-edge ViewRay MRIdian technology, thanks to a new partnership between the University of Oxford, Oxford University Hospitals (OUH) NHS Foundation Trust and GenesisCare.
World TB Day: Finding new ways to test children for tuberculosis
General Research
24 March 2021
Dr Nisreen Khambati of the Oxford Vaccine Group writes for the Oxford Science Blog on why it is vital to find new ways to test children for tuberculosis.
The RECOVERY Trial: One year on
Coronavirus COVID-19 General Research
23 March 2021
The Randomised Evaluation of COVid-19 thERapY (RECOVERY) trial was officially launched on 23 March 2020. It is the world's largest COVID-19 drug trial.
COVID-19: how to tackle vaccine hesitancy among BAME groups
Coronavirus COVID-19 General Research
22 March 2021